HCA Healthcare, Inc. Financials

Market Capitalization $110.07 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	18.19
Forward PE	15.83
Price to Sales TTM	$1.48
Price to Book MRQ	$-50.08
Enterprise to Revenue	2.08
Enterprise to EBITDA	10.26

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	8.53%
Operating Margin	15.47%
Return on Assets TTM	12.20%
Return on Equity TTM	1037.84%

Income Statement

Revenue TTM	$74,371,997,696
Revenue per Share TTM	$306.39
Quarterly Revenue Growth	9.60%
Gross Profit TTM	$30,773,000,192
EBITDA	$15,164,000,000
Net Income to Common TTM	$6,344,000,000
Diluted EPS TTM	$25.86
Quarterly Earnings Growth YoY	29.40%

Balance Sheet

Total Cash MRQ	$1,091,000,064
Total Cash per Share MRQ	$4.78
Total Debt MRQ	$
Total Debt to Equity MRQ	-21.47
Current Ratio MRQ	0.85
Book Value per Share MRQ	$-23.21

Cash Flow

Operating Cash Flow TTM	$12,835,999,744
Levered Free Cash Flow TTM	$6,101,125,120

HCA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	229,845,100
Float Shares	156,422,355
Avg 10 Volume	1,027,141
Avg 30 Volume	None
Shares Short	4,495,103
Short Ratio	3.31
Short % of Shares	2.86%
% Held by Insiders	31.30%
% Held by Institutions	61.86%

Stock Price Summary

Beta	1.37
Fifty Two Week Low	$289.98
Fifty Two Week High	$520.00
Fifty Two Week Change	36.93%
Day 50 MA	$475.44
Day 200 MA	$401.13

Dividends and Splits

Forward Annual Dividend Rate	$2.88
Forward Annual Dividend Yield	0.61%
Trailing Annual Dividend Rate	$2.88
Trailing Annual Dividend Yield	0.61%
Payout Ratio	10.90%
Dividend Date	2025-12-29
Ex Dividend Date	2025-12-15
Last Split Factor
Last Split Date